Yang et al. [67] showed that MCM2 expression in gastric cancer tissues was significantly higher than that in the normal gastric mucosa, and the levels of expression positively correlated with the prognosis, suggesting that MCM2 can be used as a novel prognostic biomarker for gastric cancer. The gene discussed is MCM2; the disease is gastric cancer.